Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score

Table 3

Logistic regression of disease control rate.

Characteristics	Univariate analysis		Multivariate analysis
	OR (95% CI)		OR (95% CI)
Lines of immunotherapy
<2	1 [ref.]		1 [ref.]
≥2	0.250 (0.102-0.616)	0.003	0.401 (0.1441.120)	0.081
Combined with other therapies
No	1 [ref.]	<0.001	1 [ref.]	0.001
Yes	7.975 (2.764-23.010)		9.548 (2.654-34.353)
LIPI
The good	1 [ref.]		1 [ref.]
The intermediate/poor	3.511 (1.218-7.134)	0.002	5.217 (1.439-18.917)	0.012

LIPI: lung immune prognostic index.